SCHEMBL1361234

SCHEMBL1361234

CCCCO[Ti](OCCCC)(OC(C)C)OC(C)C

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1361238 0.95 ADRB2 (0.35) ADRB2ADRB1ADRB3CYP3A4TSHR
SCHEMBL2379584 0.95 ADRB2 (0.35) ADRB2ADRB1ADRB3CYP3A4TSHR
SCHEMBL12544435 0.93 ADRB2 (0.33) ADRB2ADRB1ADRB3CYP3A4TSHR
SCHEMBL11405161 0.91 DNM1 (0.36) TSHR
SCHEMBL9781170 0.91 DNM1 (0.36) TSHR
SCHEMBL9781158 0.91 DNM1 (0.36) TSHR
SCHEMBL6411822 0.91 DNM1 (0.36) TSHR
SCHEMBL11707211 0.89 ADRB2 (0.31) ADRB2ADRB1ADRB3
SCHEMBL7548413 0.88 DNM1 (0.33) TSHR
SCHEMBL9781144 0.86 DNM1 (0.36) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570771-B2 Curing catalyst used for curing of polymer, production method for said curing catalyst, mositure-curable composition, and production method for cured product NITTO KASEI CO., LTD. (JP) 2026-03-10 US disclosed
EP-4682204-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2026-01-21 EP disclosed
EP-4656672-A1 METHOD FOR PRODUCING CURABLE COMPOSITION Kaneka Corporation (JP) 2025-12-03 EP disclosed
EP-4174052-B1 CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOISTURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED PRODUCT NITTO KASEI CO LTD (JP) 2025-11-26 EP disclosed
EP-4596622-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2025-08-06 EP disclosed
EP-4567075-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2025-06-11 EP disclosed
WO-2025111365-A1 METHOD OF PREPARING A MOISTURE CURABLE RESIN COMPOSITION WITH A NON-TIN CATALYST KANEKA AMERICAS HOLDING, INC. (US) 2025-05-30 WO disclosed
US-12312464-B2 Curing catalyst used for curing of polymer, moisture curable composition, and method for producing cured product NITTO KASEI CO., LTD. (JP) 2025-05-27 US disclosed
US-12285742-B2 Curing catalyst used for curing of polymer, production method for said curing catalyst, moisture-curable composition, and production method for cured article NITTO KASEI CO., LTD. (JP) 2025-04-29 US disclosed
EP-4067337-B1 CURING CATALYST USED FOR CURING OF POLYMER, MOISTURE CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT NITTO KASEI CO LTD (JP) 2025-04-23 EP disclosed
US-20100204387-A1 CURABLE COMPOSITIONS COMPOSED OF SILANES WITH TWO HYDROLYZABLE GROUPS HENKEL AG & CO. KGAA (DE) 2010-08-12 US disclosed
US-20100143712-A1 SILANE-CROSSLINKING ADHESIVE OR SEALANT COMPRISING N-SILYLALKYLAMIDES AND USE THEREOF HENKEL AG & CO. KGAA (DE) 2010-06-10 US disclosed
US-20100081757-A1 COMPOSITIONS CONSISTING OF PARTIALLY SILYL-TERMINATED POLYMERS HENKEL AG & CO. KGAA (DE) 2010-04-01 US disclosed
EP-1233014-A1 ASYMMETRIC ORGANIC PEROXIDE, CROSSLINKING AGENT COMPRISING THE SAME, AND METHOD OF CROSSLINKING WITH THE SAME NOF CORPORATION (JP) 2002-08-21 EP disclosed
US-6316046-B1 COATING COPPER WIRES, ESPECIALLY THICK ROUND WIRES OR PROFILED WIRES. SCHENECTADY INTERNATIONAL 2001-11-13 US disclosed
US-6211326-B1 ESTERIFICATION OF A POLYIMIDE SCHENECTADY INTERNATIONAL, INC. 2001-04-03 US disclosed
EP-0798344-B1 Fluorosilicone rubber composition and method of adhering it to a substrate DOW CORNING TORAY SILICONE (JP) 2000-08-09 EP disclosed
EP-0798344-A2 Fluorosilicone rubber composition and method of adhering it to a substrate Dow Corning Toray Silicone Company, Limited (JP) 1997-10-01 EP disclosed
US-5536791-A TRIS-2-HYDROXYETHYL ISOCYANURATE POLYESTER, BISMALEIMIDE RESIN, CATALYST BASF LACKE + FARBEN, AG (DE) 1996-07-16 US disclosed
US-4446300-A DIELECTRICS, FORMING TRIS/2-HYDROXYETHYL/ISOCYANURATE IN SITU FROM CYANURIC ACID AND ETHYLENE CARBONATE THE P. D. GEORGE COMPANY (US) 1984-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570771-B2 Curing catalyst used for curing of polymer, production method for said curing catalyst, mositure-curable composition, and production method for cured product RPS6KB1, RPS6KA1, RPS6KB2 ADRB2 1818/4885ADRB1 1801/4885ADRB3 2794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.